Anlotinib in Treatment of Recurrent Small Cell Lung Cancer
Clinical trial NCT03732846 · UNKNOWN
Trial details
- NCT number
- NCT03732846
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2020-05-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.